Clinical Trial Update: Extended Management and Measurement of Autism [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluating extended management and measurement of autism, sponsored by Neuropharm, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Snippet

Sponsor: Neuropharm | Conditions: Autistic Disorder | Phase 3 | Status: TERMINATED